TRML β€” TOURMALINE BIO INC COM

Ownership history in AMALGAMATED BANK  Β·  6 quarters on record

This page tracks every 13F SEC filing in which AMALGAMATED BANK reported a position in TOURMALINE BIO INC COM (TRML). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 6 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 567 -232 -29.0% 0.00% $27K β€”
2025 Q2 UNCHANGED 799 β€” 0% 0.00% $13K β€”
2025 Q1 UNCHANGED 799 β€” 0% 0.00% $12K β€”
2024 Q4 UNCHANGED 799 β€” 0% 0.00% $16K β€”
2024 Q3 UNCHANGED 799 β€” 0% 0.00% $21K β€”
2024 Q2 INITIATED 799 β€” β€” 0.00% $10K β€”

🏒 Other funds also holding TRML

As of 2025 Q3 β€” sorted by position size

Qiming U.S. Ventures Management, LLC 3Y 63.76% PFIZER INC 13.91% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 13.27% QVT Financial LP 3Y 7Y 7.27% Chicago Capital Management, LLC 3Y 7Y 4.81% TCG Crossover Management, LLC 3Y 3.09% Vivo Capital, LLC 3Y 7Y 2.28% HARVEST MANAGEMENT LLC 3Y 7Y 2.07% Versor Investments LP 3Y 7Y 1.91% NEXPOINT ASSET MANAGEMENT, L.P. 3Y 1.89%
← Back to AMALGAMATED BANK Holdings